SEC Form SC 13G filed by iCAD Inc.

3/15/23 3:15:23 PM ET

Medical/Dental Instruments

Health Care

Get the next $ICAD alert in real time by email

SC 13G 1 ICAD.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 iCAD Inc (Name of Issuer) Common (Title of Class of Securities) 44934S206 (CUSIP Number) March 10, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ X ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 44934S206 13G Page 2 of 6 Pages 1. NAMES OF REPORTING PERSONS OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Pura Vida Investments, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) [ ] (b) [ x ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 1,277,214* 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 1,277,214* 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,277,214* 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.02%** 12. TYPE OF REPORTING PERSON (see instructions) IA CUSIP No. 44934S206 13G Page 3 of 6 Pages 1. NAMES OF REPORTING PERSONS OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Efrem Kamen 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) [ ] (b) [ x ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION USA NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 1,277,214* 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 1,277,214* 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,277,214* 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.02%** 12. TYPE OF REPORTING PERSON (see instructions) IN, HC CUSIP No. 44934S206 13G Page 4 of 6 Pages Item 1. (a) Name of Issuer iCAD, Inc. (b) Address of Issuers Principal Executive Offices 98 Spit Brook Road, Suite 100 Nashua, NH 03062 Item 2. (a) Name of Person Filing Pura Vida Investments, LLC Efrem Kamen (collectively, the "Filers"). (b) The address of the principal place of the Filers is located at: Pura Vida Investments, LLC 512 West 22nd Street, 7th Floor New York, NY 10011 (c) For citizenship of Filers, see Item 4 of the cover sheet for each Filer. (d) Title of Class of Securities Common (e) CUSIP Number 03837C106 Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [x] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1) (ii)(F); (g) [ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1) (ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). CUSIP No. 44934S206 13G Page 5 of 6 Pages Item 4. Ownership. (a) Amount beneficially owned: Pura Vida Investments LLC 1,277,214* shares Efrem Kamen 1,277,214* shares (b) Percent of class: Pura Vida Investments LLC 5.02%* Efrem Kamen 5.02%* (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 0 (ii) Shared power to vote or to direct the vote Pura Vida Investments LLC 1,277,214* shares Efrem Kamen 1,277,214* shares (iii) Sole power to dispose or to direct the disposition of 0 (iv) Shared power to dispose or to direct the disposition of Pura Vida Investments, LLC 1,277,214* shares Efrem Kamen 1,277,214* shares *Shares reported herein are owned by Pura Vida Master Fund, Ltd. (the "Pura Vida Master Fund") and certain separately managed accounts (the "Managed Accounts," collectively the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager or sub-adviser to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI. Efrem Kamen serves as the managing member of PVI. By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the Shares owned directly by the Pura Vida Master Fund and the Managed Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the Shares for purposes of Section 13 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the Shares reported herein except to the extent of the Reporting Persons pecuniary interest therein. Item 5. Ownership of Five Percent or Less of a Class. N/A Item 6. Ownership of More than Five Percent on Behalf of Another Person. N/A Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. N/A CUSIP No. 44934S206 13G Page 6 of 6 Pages Item 8. Identification and Classification of Members of the Group. N/A Item 9. Notice of Dissolution of Group. N/A Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Exhibits. Exhibit A Joint Filing Agreement. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: March 14, 2023 Pura Vida Investments, LLC By: /s/ Efrem Kamen, Managing Member

Get the next $ICAD alert in real time by email

Date

Price Target

Rating

Analyst

4/17/2025

Buy → Neutral

BTIG Research

4/17/2025

Buy → Hold

Laidlaw

1/18/2022

Buy → Neutral

Guggenheim

1/5/2022

$22.00 → $16.00

Outperform

Oppenheimer

11/10/2021

$22.00 → $18.00

Market Outperform

JMP Securities

SEC Form SC 13G filed by iCAD Inc.

3/15/23 3:15:23 PM ET

$ICAD

Medical/Dental Instruments

Health Care

Get the next $ICAD alert in real time by email

Date

Price Target

Rating

Analyst

4/17/2025

Buy → Neutral

BTIG Research

4/17/2025

Buy → Hold

Laidlaw

1/18/2022

Buy → Neutral

Guggenheim

1/5/2022

$22.00 → $16.00

Outperform

Oppenheimer

11/10/2021

$22.00 → $18.00

Market Outperform

JMP Securities

SEC Form SC 13G filed by iCAD Inc.

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for
$ICAD

SEC Form SC 13G filed by iCAD Inc.

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for
$ICAD

$ICAD
Press Releases

Fastest customizable press release news feed in the world

iCAD Reports Financial Results for First Quarter Ended March 31, 2025

Clinical AI Platforms Expand Globally Amid Regulatory and Market Tailwinds

iCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft's Precision Imaging Network (PIN)

$ICAD
SEC Filings

SEC Form 425 filed by iCAD Inc.

SEC Form 425 filed by iCAD Inc.

SEC Form 425 filed by iCAD Inc.

$ICAD
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Officer Brown Dana R gave a grant of 11,483 shares, decreasing direct ownership by 17% to 54,350 units (SEC Form 4)

Officer Lonnqvist Eric gave a grant of 7,345 shares, decreasing direct ownership by 46% to 8,488 units (SEC Form 4)

Officer Brown Dana R was granted 25,833 shares, increasing direct ownership by 65% to 65,833 units (SEC Form 4)

$ICAD
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

iCAD downgraded by BTIG Research

iCAD downgraded by Laidlaw

icad downgraded by Guggenheim

$ICAD
Leadership Updates

Live Leadership Updates

iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer

iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)

iCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member

$ICAD
Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by iCAD Inc. (Amendment)

SEC Form SC 13G/A filed by iCAD Inc. (Amendment)